drugset / Trial / NCT03445715
ART-I02 in Patients With Rheumatoid Arthritis With Inflamed Wrists
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate the safety and tolerability of a single intra-articular administration of ART-I02 (AAV5.NF-kB.IFN-β), a recombinant adeno-associated virus (AAV) type 5 vector in subjects with RA and active arthritis of a wrist.
Timeline
- Start
- 2018-01-03
- Primary completion
- 2019-09
- Completion
- 2020-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ART-I02 | Gene therapy (AAV / viral vector) | 2.4e+12 vg | Other |
| Subject | ART-I02 | Gene therapy (AAV / viral vector) | 2.4e+13 vg | Other |